Microbicides 2004

Microbicides 2004

Microbicides 200428-31 March 2004, Hilton London MetropoleThe conference42 million men, women and children worldwide were living with HIV by the end of December 2002 (source: UNAIDS), including five million newly-infected during that year alone. Another 45 million people will become infected between 2002 and 2010, unless the current transmission rates can be vastly reduced. Of the 42 million, 29.4 million live in sub-Saharan Africa and 58% of them are women. Not only are women more susceptible to HIV infection, many are powerless to insist on the use of condoms or other methods of protecting themselves. In this context, and with the knowledge that an effective HIV vaccine is unlikely to be available for several years, the need for an effective topical microbicide grows ever more urgent. 2004 should prove to be a landmark year in the field of microbicide development as the first Phase III trials of novel products are due to start – the next step along the road to making a microbicide available to the millions worldwide in desperate need of protection.The aims of the Microbicides 2004 conference are to:Report novel or innovative work in the microbicides fieldProvide updates on recent microbicides research, divided into three tracks: basic science, clinical science, and behavioural science (including public health and the microbicide marketplace)Provide a forum for the discussion of new developments in microbicide research including ethical, clinical, behavioural and methodological issuesPresent opportunities for knowledge-sharing between microbicide researchers, public-health workers and advocacy organisations.There will be an opening ceremony on the evening of Sunday 28 March at which politicians, policy makers and the international media are expected. The conference will run for a full three days, each of which will contain:Scientific overviews and presentations with plenary sessions, invited lecturers and presentations of original researchWorkshops to review issues unique to microbicides such as trial design and outcome measures, and ethical issues in the clinical trials of microbicidesPoster sessions. Focus on LondonFollowing the successful Microbicides conferences in Washington in 2000 and Antwerp in 2002, March 2004 sees the focus move to London.The venue is the Hilton Metropole Hotel, two minutes by taxi from Paddington station and the Heathrow Express, with a journey time from the airport of 15 minutes. The hotel is in walking distance of Hyde Park and London’s main shopping streets, and close to Imperial College. Accommodation will be available at the venue and other hotels in the vicinity.London in March offers a variety of diversions for out-of-conference relaxation, including sight-seeing and shopping; the arts and the theatre; and pubs, clubs and restaurants to suit every taste. Conference staff will be on hand to help delegates plan their spare time.To book your place or find out more information, e-mail info@microbicides2004.org.uk or telephone the Event Office on +44 (0) 20 7720 4411

02168 MICROBICIDES THE ULTIMATE PREFERENCE OF ALL THE WOMEN PREVENTION OPTIONS

02187 PHASE II OF KNOWLEDGE, ATTITUDES & PERCEPTIONS TOWARDS THE USE OF MICROBICIDES: TANGA RELIGIOUS LEADERS RESPONSES

02189 HIV PREVENTION AMONG SEX WORKERS IN SENEGAL

02201 GRASSROOTS MEDIA CRY OUT: WHAT MICROBICIDES?

02217 HIV/STIs PREVENTION THROUGH MICROBICIDES: A STUDY SURVEY AMONG FAMILY PLANNING CLINIC ATTENDEES IN NIGERIA

02223 PEER EDUCATION IN HIV PREVENTION WITH HIGH RISK YOUTH

02338 MICROBICIDES, CONDOMS OR BOTH? VIEWS OF MEDICAL PRACTITIONERS IN TWO STATES OF NORTH EAST NIGERIA

02350 INTENTIONS TO BECOME PREGNANT: DATA FROM A FEASIBILITY STUDY FOR A PHASE III MICROBICIDE TRIAL

02356 EVALUATION OF KNOWLEDGE AND ACCEPTABILITY OF MICROBICIDES BY COMMERCIAL SEX WORKERS IN LAGOS

02380 MICROBICIDES AN ANOTHER APPROACH TO KEEP STI/HIV INTERVENTION VIABLE

02382 NEED OF THE HOUR – A WOMAN CONTROLLED PREVENTION TECHNIQUE

02390 SEX WORKER CONDOM USE PATTERNS BY PARTNER TYPE

02402 PREVALENCE AND TYPES OF STIS AMONG FEMALES OF REPRODUCTIVE AGE ATTENDING A REHABILITATION CENTRE IN LAGOS, NIGERIA

02408 BEHAVIOURAL CHALLENGES TO MICROBICIDE GEL ACCEPTANCE AND USE IN SUB-SAHARAN AFRICA

02482 ENHANCING KNOWLEDGE TRANSFER FOR THE SUCCESSFUL INTRODUCTION OF MICROBICIDES IN DEVELOPING COUNTRIES

02484 GENDER MARGINALIZATION - A CHALLENGE FORMICROBICIDES AS A PREVENTION OPTION FOR WOMEN IN INDIA

02497 MICROBICIDES AWARENESS AMONG BIOMEDICAL STAFF AT THE UNIVERSITY TEACHING HOSPITAL IN LUSAKA,ZAMBIA

02528 ACCEPTABILITY OF A VAGINAL GEL AS A PROTECTIVE BARRIER AGAINST STDS AND HIV IN ADOLESCENT GIRLS AND SEX WORKERS IN DAKAR

02578 CANADA: APPLYING RIGHTS-BASED APPROACH TO MOBILIZE COMMUNITY FOR MICROBICIDES

02601 MICROBICIDES, DIAPHRAGMS, MALE CONDOMS, AND HIV VACCINES: INTENTIONS AMONG A SAMPLE OF U.S. STUDENTS

02636 THE CHALLENGES OF NATIONALLY REPRESENTATIVE ACCEPTABILITY STUDIES IN A MULTI-CULTURAL CONTEXT

02697 The Female Condom: seeing the ready beaten trail to start paving the path